What's Happening With HIMS Stock? [Forbes]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Forbes
SOPA Images/LightRocket via Getty Images The stock price of Hims & Hers Health (NYSE: HIMS) , a telehealth platform, has risen a solid 14% in a week. Much of this move came after the U.S. FDA asked for more time to confirm the shortage of Eli Lilly's weight loss drug – Zepbound. The shortage of GLP-1 drugs bodes well for Hims & Hers, which sells generic versions of weight loss drugs. HIMS stock has had a volatile ride this month, with its stock plunging 30% from levels of around $28 on November 13 to $19 on November 15, before rising again to $24 now. The decline HIMS stock saw can be attributed to Amazon's launch of a rival service. Amazon will offer lower pricing for a clinical visit and treatment plan for a range of common health, beauty, and lifestyle concerns. Looking at a slightly longer term, HIMS stock has seen a solid 270% rise from levels of around $7 in early 2022 to $24 now. This can primarily be attributed to: a rise in the company's revenue from $272 million in
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss JourneysBusiness Wire
- Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead [Seeking Alpha]Seeking Alpha
- Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at TD Cowen. They now have a $28.00 price target on the stock.MarketBeat
- Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/4/24 - Beat
HIMS
Sec Filings
- 11/21/24 - Form 8-K
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- HIMS's page on the SEC website